1. Home
  2. BEAM vs ENLT Comparison

BEAM vs ENLT Comparison

Compare BEAM & ENLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • ENLT
  • Stock Information
  • Founded
  • BEAM 2017
  • ENLT 2008
  • Country
  • BEAM United States
  • ENLT Israel
  • Employees
  • BEAM N/A
  • ENLT N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • ENLT
  • Sector
  • BEAM Health Care
  • ENLT
  • Exchange
  • BEAM Nasdaq
  • ENLT Nasdaq
  • Market Cap
  • BEAM 1.9B
  • ENLT 1.9B
  • IPO Year
  • BEAM 2020
  • ENLT 2023
  • Fundamental
  • Price
  • BEAM $29.01
  • ENLT $15.81
  • Analyst Decision
  • BEAM Buy
  • ENLT Buy
  • Analyst Count
  • BEAM 10
  • ENLT 4
  • Target Price
  • BEAM $47.67
  • ENLT $19.00
  • AVG Volume (30 Days)
  • BEAM 1.2M
  • ENLT 29.6K
  • Earning Date
  • BEAM 11-05-2024
  • ENLT 11-13-2024
  • Dividend Yield
  • BEAM N/A
  • ENLT N/A
  • EPS Growth
  • BEAM N/A
  • ENLT N/A
  • EPS
  • BEAM N/A
  • ENLT 0.41
  • Revenue
  • BEAM $349,643,000.00
  • ENLT $358,416,000.00
  • Revenue This Year
  • BEAM N/A
  • ENLT $428.35
  • Revenue Next Year
  • BEAM $10.82
  • ENLT $27.54
  • P/E Ratio
  • BEAM N/A
  • ENLT $37.79
  • Revenue Growth
  • BEAM 328.73
  • ENLT 47.65
  • 52 Week Low
  • BEAM $20.84
  • ENLT $14.09
  • 52 Week High
  • BEAM $49.50
  • ENLT $19.82
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 56.94
  • ENLT 46.49
  • Support Level
  • BEAM $24.96
  • ENLT $15.46
  • Resistance Level
  • BEAM $29.53
  • ENLT $16.55
  • Average True Range (ATR)
  • BEAM 2.05
  • ENLT 0.40
  • MACD
  • BEAM -0.04
  • ENLT -0.08
  • Stochastic Oscillator
  • BEAM 67.05
  • ENLT 28.69

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About ENLT Enlight Renewable Energy Ltd.

Enlight Renewable Energy Ltd develops, finances, constructs, owns, and operates utility-scale renewable energy projects. It operates across the three largest renewable segments namely solar, wind and energy storage. Geographically, it operates in the United States, Israel and 9 European countries.

Share on Social Networks: